Latest
-
Medicare Lists First 10 Drugs for Talks On Lowering Your Costs
New prices for Medicare Part D drugs on list expected in 2026.
-
Hospitals Say Increased Medicare Reimbursement Is Not Enough: Kiplinger Economic Forecasts
Economic Forecasts Medicare will bump up hospital reimbursements by 3.1% in 2024, but the industry says it's not enough as it comes off its worst financial year of the pandemic.
Economic Forecasts -
More Funding Going Toward Nursing Workforce
Department of Health and Human Services is investing $100 million in nursing workforce.
-
Will Weight-Loss Drugs Spike Medicare Costs?: The Kiplinger Letter
Economic Forecasts Lawmakers are trying to get weight-loss drugs like Wegovy covered by Medicare. Long-term savings are possible, but it could cost the program $27 billion.
Economic Forecasts -
The High Costs of Senior Caregiving
Out-of-pocket costs for caregivers average about $7,000 per year. Here's how to get some help.
-
More Weight-Loss Drugs, Like Ozempic, are in the Works: Kiplinger Economic Forecasts
Economic Forecasts Pharmaceutical companies are developing more weight-loss drugs similar to Ozempic, but these injectables are still expensive.
Economic Forecasts -
Financial Planning in Retirement: Seeing All the Angles
In addition to investments, your financial adviser should be talking to you about insurance, Medicare, Social Security, long-term care, estate planning and tax planning.
-
Medicare Drug Price Negotiations Latest: Kiplinger Economic Forecasts
Economic Forecasts Medicare drug price negotiations: Early signs have emerged of how these key talks will be handled.
Economic Forecasts -
New Call for Medicare to End Restrictions on Alzheimer’s Disease Treatments
While there is no known cure for Alzheimer’s disease, there are promising — but expensive — treatments.
